Sabby Management, LLC Cocrystal Pharma, Inc. Transaction History

Sabby Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $163,261 - $2.18 Million	-604,671 Reduced 10.27%	5,284,256 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.55 $105,218 - $152,289	276,890 Added 4.93%	5,888,927 $2.41 Million
Q1 2022 May 16, 2022	SELL	$0.48 - $0.71 $60,519 - $89,518	-126,083 Reduced 2.2%	5,612,037 $3.09 Million
Q4 2021 Feb 14, 2022	BUY	$0.65 - $1.02 $372,257 - $584,158	572,704 Added 11.09%	5,738,120 $3.73 Million
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.25 $954,693 - $1.18 Million	-945,241 Reduced 15.47%	5,165,416 $5.42 Million
Q2 2021 Aug 16, 2021	BUY	$1.08 - $2.14 $6.6 Million - $13.1 Million	6,110,657 New	6,110,657 $7.64 Million
Q4 2020 Feb 16, 2021	SELL	$0.8 - $2.16 $2.13 Million - $5.76 Million	-2,667,293 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.86 - $2.36 $2.29 Million - $6.29 Million	2,667,293 New	2,667,293 $2.48 Million
Q2 2020 Aug 14, 2020	SELL	$0.7 - $1.58 $274,544 - $619,685	-392,206 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.48 - $2.19 $188,258 - $858,931	392,206 New	392,206 $278,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.